Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Jenkins

Showing results (521-530 of 546) with videos related to

Pageof 55
Sort By:
Nature Communications|June 24, 2026
Multimodal blood based proteomic profiling reveals insights into mechanisms of immunotherapy resistanceSamuel J Wright, Izabella Zamora, Milan Parikh, et al.
Biorxiv : the Preprint Server for Biology|July 14, 2025
Sialylated CD43 is a glyco-immune checkpoint for macrophage phagocytosisJooho Chung, Mounica Vallurupalli, Sarah Noel, et al.
Science (New York, N.Y.)|July 11, 2024
Mutant IDH1 inhibition induces dsDNA sensing to activate tumor immunityMeng-Ju Wu, Hiroshi Kondo, Ashwin V Kammula, et al.
Cell Systems|August 25, 2017
Decomposing Oncogenic Transcriptional Signatures to Generate Maps of Divergent Cellular StatesJong Wook Kim, Omar O Abudayyeh, Huwate Yeerna, et al.
Neuro-Oncology|June 28, 2025
Mesothelin is a surface antigen present on human meningioma and can be effectively targeted by CAR T-cellsRishab Ramapriyan, Fred G Barker, Leland G Richardson, et al.
Cell|November 3, 2018
Defining T Cell States Associated with Response to Checkpoint Immunotherapy in MelanomaMoshe Sade-Feldman, Keren Yizhak, Stacey L Bjorgaard, et al.
Nature Communications|September 29, 2025
Genome-resolved biogeography of Phaeocystales, cosmopolitan bloom-forming algaeZoltán Füssy, Robert H Lampe, Kevin R Arrigo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 23, 2024
Mesothelin CAR T Cells Secreting Anti-FAP/Anti-CD3 Molecules Efficiently Target Pancreatic Adenocarcinoma and its StromaMarc Wehrli, Samantha Guinn, Filippo Birocchi, et al.
Biorxiv : the Preprint Server for Biology|December 3, 2025
Lymphotoxin-driven cancer cell eradication by tumoricidal CD8<sup>+</sup> TILHongyan Xie, Aiping Jiang, Aonkon Dey, et al.
Science (New York, N.Y.)|April 9, 2026
Sialylated CD43 forms a glyco-immune barrier that restrains antileukemic immunityJooho Chung, Mounica Vallurupalli, Sarah Noel, et al.
Pageof 55

Showing results (521-530 of 546) with videos related to

Sort By:
Pageof 55
Nature Communications|June 24, 2026
Multimodal blood based proteomic profiling reveals insights into mechanisms of immunotherapy resistanceSamuel J Wright, Izabella Zamora, Milan Parikh, et al.
Biorxiv : the Preprint Server for Biology|July 14, 2025
Sialylated CD43 is a glyco-immune checkpoint for macrophage phagocytosisJooho Chung, Mounica Vallurupalli, Sarah Noel, et al.
Science (New York, N.Y.)|July 11, 2024
Mutant IDH1 inhibition induces dsDNA sensing to activate tumor immunityMeng-Ju Wu, Hiroshi Kondo, Ashwin V Kammula, et al.
Cell Systems|August 25, 2017
Decomposing Oncogenic Transcriptional Signatures to Generate Maps of Divergent Cellular StatesJong Wook Kim, Omar O Abudayyeh, Huwate Yeerna, et al.
Neuro-Oncology|June 28, 2025
Mesothelin is a surface antigen present on human meningioma and can be effectively targeted by CAR T-cellsRishab Ramapriyan, Fred G Barker, Leland G Richardson, et al.
Cell|November 3, 2018
Defining T Cell States Associated with Response to Checkpoint Immunotherapy in MelanomaMoshe Sade-Feldman, Keren Yizhak, Stacey L Bjorgaard, et al.
Nature Communications|September 29, 2025
Genome-resolved biogeography of Phaeocystales, cosmopolitan bloom-forming algaeZoltán Füssy, Robert H Lampe, Kevin R Arrigo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 23, 2024
Mesothelin CAR T Cells Secreting Anti-FAP/Anti-CD3 Molecules Efficiently Target Pancreatic Adenocarcinoma and its StromaMarc Wehrli, Samantha Guinn, Filippo Birocchi, et al.
Biorxiv : the Preprint Server for Biology|December 3, 2025
Lymphotoxin-driven cancer cell eradication by tumoricidal CD8<sup>+</sup> TILHongyan Xie, Aiping Jiang, Aonkon Dey, et al.
Science (New York, N.Y.)|April 9, 2026
Sialylated CD43 forms a glyco-immune barrier that restrains antileukemic immunityJooho Chung, Mounica Vallurupalli, Sarah Noel, et al.
Pageof 55